[1]
« In Silico Investigation of the Interactions of Piflufolastat F-18 and Flotufolastat F-18 Radiopharmaceuticals with Biological Targets Relevant to Prostate Cancer Diagnosis », Rev. Sci. Santé, vol. 5, nᵒ 1, p. 27–34, févr. 2026, doi: 10.71004/rss.026.v5.i1.50.